The <i>JAK2</i> 46/1 haplotype influences PD-L1 expression
Gonzalo Carreño‐Tarragona, Miguel Manzanares(Centro de Biología Molecular Severo Ochoa), Joaquín Martínez‐López(Hospital Universitario 12 De Octubre), Nicholas C.P. Cross(University of Southampton), María Tiana(Universidad Francisco de Vitoria), Raquel Rouco(University of Geneva), Jesús Victorino(Spanish National Centre for Cardiovascular Research), Alejandra Leivas(Spanish National Cancer Research Centre), Rosa Ayala(Hospital Universitario 12 De Octubre), Roberto García-Vicente(Research Institute Hospital 12 de Octubre), Andrew Chase(Wessex Regional Genetics Laboratory), Andrea Maidana(Centro de Biología Molecular Severo Ochoa), William Tapper(University of Southampton)
Cited by 4
Related Papers
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719